We are live on ! Find out more
BCTXW

BriaCell Therapeutics Corp Warrant

Delisted

BCTXW was delisted on the 26th of February, 2026.

7 hedge funds and large institutions have $8.31K invested in BriaCell Therapeutics Corp Warrant in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

180% more capital invested

Capital invested by funds: $2.97K → $8.31K (+$5.34K)

133% more funds holding

Funds holding: 37 (+4)

3.27% more ownership

Funds ownership: 2.99%6.27% (+3.3%)

Holders
7
Holders Change
+4
Holders Change %
+133.33%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$3.54K +$3.35K +67,111 New
RAM
2
Redmond Asset Management
Virginia
$2.35K
HF
3
HRT Financial
New York
$1K +$1.04K +20,844 New
VF
4
Virtu Financial
New York
$1K +$1.31K +26,293 New
LGM
5
L1 Global Manager
$370 +$349 +7,000 New
NFSG
6
Newbridge Financial Services Group
Florida
$53
TSS
7
Two Sigma Securities
New York
-$575 -18,264 Closed
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
+$11 +225 New

BCTXW Hedge Fund Activity: Q4 2025 in Review

7 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q4 2025, worth a combined $8.31K — up 180% from $2.97K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new BCTXW positions and 1 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.35K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $575 sold.

  • 7 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q4 2025, up from 3 in Q3 2025.
  • Funds reported $8.31K of BriaCell Therapeutics Corp Warrant stock for Q4 2025, up 180% quarter-over-quarter.
  • 5 funds opened new BriaCell Therapeutics Corp Warrant positions in Q4 2025 and 1 closed out, a net change of +4 holders.
  • The largest BriaCell Therapeutics Corp Warrant buyer in Q4 2025 was Susquehanna International Group, an estimated $3.35K added.
  • The largest BriaCell Therapeutics Corp Warrant seller in Q4 2025 was Two Sigma Securities, an estimated $575 sold.

Based on aggregated 13F filings for Q4 2025.